Pfizer Shorted NYU On Cancer Drug Royalties, Suit Says
New York University on Thursday slapped Pfizer Inc. with a breach of contract suit for allegedly failing to pay promised royalties on a cancer medicine the university says it was instrumental...To view the full article, register now.
Already a subscriber? Click here to view full article